METHOD OF EXPERIMENTAL AMYLOIDOSIS MODELLING IN ANIMALS
FIELD: medicine. ^ SUBSTANCE: invention refers to experimental medicine and can be used for amyloidosis modelling in animals. It is enabled as follows. Native pig plasma is injected to golden hamsters every second day at 0.025 ml/g of body weight within 60 experimental days. Method provides adequate...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine. ^ SUBSTANCE: invention refers to experimental medicine and can be used for amyloidosis modelling in animals. It is enabled as follows. Native pig plasma is injected to golden hamsters every second day at 0.025 ml/g of body weight within 60 experimental days. Method provides adequate model reproduction that makes it possible to analyse pathogenesis, prevent and treat amyloidosis, specifically when researching functional kidneys health, blood circulation system, mineral metabolism and other indicators of experimental animals. ^ EFFECT: model reproduction that makes it possible to analyse pathogenesis, prevent and treat amyloidosis. ^ 1 ex, 5 dwg |
---|